Prognostic Markers in the Treatment of Abiraterone Acetate + Prednisolone and Enzalutamide in Castration-Resistant Metastatic Prostate Cancer
Eurasian Journal of Medical Investigation（2022）
摘要
DOI: 10.14744/ejmi.2022.22832 EJMI 2022;6(1):45–49
更多查看译文
关键词
prostate cancer,abiraterone acetate,enzalutamide,prednisolone,castration-resistant
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要